Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China And Taiwan Move Toward Clinical Data Mutual Acceptance, Regulatory Harmonization

This article was originally published in PharmAsia News

Executive Summary

China and Taiwan's top health regulators have signed an agreement to harmonize clinical and non-clinical studies toward mutual data acceptance. The deal could open doors for more Taiwanese drugs in the Chinese market, industry experts say
Advertisement

Related Content

Bayer Global Regulatory Affairs Head Joseph Scheeren On MRCT In China: An Interview With PharmAsia News
Slow Take Off For Taiwan’s Fast-Track NDA Program
More Efforts Needed To Make Taiwan A Springboard To China – BioBusiness Asia Conference
Case Study: Cross-Strait Agreement Could Shorten IND Timeframe For Products Entering China (Part 1 of 2)
China Enhances Data Management, Communication For IND Approvals
Taiwan's Health Minister Resigns Again After Failing To Reform National Health Insurance Scheme
Asia Raises Bar for New Drugs, Manufacturers With Tougher CMC Reviews, GMP Inspections (Part 1)
Asia Raises Bar for New Drugs, Manufacturers With Tougher CMC Reviews, GMP Inspections (Part 1)
Taiwan Eyes Cross-strait Biotech Cooperation with China
Taiwan Announces $1.9 Billion Mega Fund To Nurture Biotech Industry
Advertisement
UsernamePublicRestriction

Register

SC076336

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel